Primary Raynaud's phenomenon (PRP) is a common condition characterized by transient ischemia in the extremities in response to cold or emotions, which does not progress to digital ulcerations. The pathophysiology of PRP is multifactorial and complex, and while PRP is considered as a benign condition, it can be associated with significant disability during the cold season. The objective of this talk is to further clarify how a diagnosis of PRP can be performed, and to review the different pharmacological and non pharmacological treatments currently used in the management of RP, from their mechanism of action to the available evidence regarding their efficacy. We will also address the issue of drug-induced RP.
Disclosure of Interest J.-L. Cracowski Grant/research support from: Pfizer; Bioprojet
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.